Recognition and Management of Toxicities from Immunotherapy and Targeted Therapy in Elderly Patients with Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recognition and Management of Toxicities from Immunotherapy and Targeted Therapy in Elderly Patients with Lung Cancer

Published:2021-05 Issue: Volume:1 Page:73-84
ISSN:2666-853X
Container-title:Advances in Oncology
language:en
Short-container-title:Advances in Oncology

Author:

Cervantez Sherri R.,Karnad Anand B.

Publisher

Elsevier BV

Reference82 articles.

1. Global cancer incidence and mortality rates and trends—an update;Torre;Cancer Epidemiol Biomarkers Prev,2015

2. Cancer statistics 2019;Siegel;CA Cancer J Clin,2019

3. Cancer treatment and survivorship statistics, 2019;Miller;CA Cancer J Clin,2019

4. Utilization of antineoplastic agents and Medicare spending in elderly patients with extensive-stage small cell lung cancer between 2001 and 2013;Shah;JCO Oncol Pract,2020

5. Impact of age and comorbidity on non-small cell lung cancer treatment in older veterans;Wang;J Clin Oncol,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP